Merck’s $1.85 Billion Acquisition of Pandion Therapeutics

Troutman Pepper Hamilton Sanders LLP advised Pandion Therapeutics, Inc. on the deal.Pandion Therapeutics, Inc., a clinical-stage biotechnology company developing novel therapeutics for those living with autoimmune…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now